Candriam S.C.A. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 127 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$444,296
-52.4%
44,489
-46.5%
0.00%
-50.0%
Q4 2022$933,483
-10.5%
83,202
-19.1%
0.01%
-14.3%
Q3 2022$1,043,000
-84.9%
102,828
-78.4%
0.01%
-85.1%
Q2 2021$6,907,000
-1.7%
475,696
+71.3%
0.05%
-39.7%
Q1 2020$7,028,000
-2.3%
277,7000.0%0.08%
+1.3%
Q4 2019$7,190,000
+32.0%
277,700
-0.7%
0.08%
+6.9%
Q3 2019$5,449,000
+19.8%
279,7000.0%0.07%
+26.3%
Q2 2019$4,547,000
-28.3%
279,7000.0%0.06%
-29.6%
Q1 2019$6,341,000
-11.4%
279,7000.0%0.08%
-26.4%
Q4 2018$7,157,000
-14.0%
279,700
+9.8%
0.11%
-0.9%
Q3 2018$8,321,000
+1114.7%
254,700
+1173.5%
0.11%
+825.0%
Q3 2017$685,000
-42.7%
20,000
-33.3%
0.01%
-45.5%
Q2 2017$1,195,000
-53.6%
30,000
-57.1%
0.02%
-56.0%
Q1 2017$2,578,000
+7.8%
70,000
-6.7%
0.05%
-9.1%
Q4 2016$2,391,00075,0000.06%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders